MedTrace Logo

Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer

NCT02501759 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2019-04-03

Study results available
· View outcomes & findings →

Summary

This pilot clinical trial studies transrectal magnetic resonance imaging (MRI)-guided biopsy to see how well it works in identifying cancer in patients with suspected prostate cancer who are scheduled to undergo standard biopsy. Transrectal MRI-guided biopsy uses a thin needle inserted through the rectum into the prostate and takes a sample of tissue, guided by MRI. MRI uses magnets to take pictures of the prostate and may be able to identify cancer. Transrectal MRI-guided biopsy may be more accurate and cause patients less pain than standard ultrasound-guided biopsy. It is not yet known whether transrectal MRI-guided biopsy is more effective than ultrasound-guided biopsy in identifying prostate cancer.

Conditions

  • Health Status Unknown
  • Prostate Carcinoma

Interventions

PROCEDURE

3 Tesla Magnetic Resonance Imaging

Undergo diagnostic multiparametric endorectal MRI with gadodiamide contrast

RADIATION

Gadodiamide

Given IV

PROCEDURE

Multiparametric Magnetic Resonance Imaging

Undergo diagnostic multiparametric endorectal MRI with gadodiamide contrast

PROCEDURE

Transrectal Biopsy

Undergo transrectal MRI-guided biopsy

PROCEDURE

Ultrasound-Guided Prostate Biopsy

Undergo TRUS-guided biopsy

Sponsors & Collaborators

  • Medical Research Foundation, Oregon

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • OHSU Knight Cancer Institute

    lead OTHER

Principal Investigators

  • Fergus Coakley · OHSU Knight Cancer Institute

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-12-31
Completion
2017-02-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02501759 on ClinicalTrials.gov